Literature DB >> 12890739

Emerging roles of BRCA1 alternative splicing.

T I Orban1, E Olah.   

Abstract

Germline mutations of the BRCA1 gene predispose individuals mainly to the development of breast and/or ovarian cancer. However, the exact function of the gene is still unclear, although the encoded proteins are involved in various cellular processes, including transcriptional regulation and DNA repair pathways. Several BRCA1 splice variants are found in different tissues, but in spite of intense investigations, their regulation and possible functions are poorly understood at the moment. This review summarises current knowledge on the roles of these splice variants and the mechanisms responsible for their formation. Because alternative splicing is now widely accepted as an important source of genetic diversity, elucidating the functions of the BRCA1 splice variants would help in the understanding of the exact role(s) of this tumour suppressor. This should help to resolve the current paradox that, despite its seemingly vital cellular functions, mutations of this gene are associated with tissue specific tumour formation predominantly in the breast and the ovary.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890739      PMCID: PMC1187320          DOI: 10.1136/mp.56.4.191

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  88 in total

1.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

Authors:  Y Wang; D Cortez; P Yazdi; N Neff; S J Elledge; J Qin
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 2.  DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis.

Authors:  G K Dasika; S C Lin; S Zhao; P Sung; A Tomkinson; E Y Lee
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

3.  The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells.

Authors:  V Budhram-Mahadeo; D Ndisang; T Ward; B L Weber; D S Latchman
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

4.  Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.

Authors:  R P Zweemer; P J van Diest; R H Verheijen; A Ryan; J J Gille; R H Sijmons; I J Jacobs; F H Menko; P Kenemans
Journal:  Gynecol Oncol       Date:  2000-01       Impact factor: 5.482

5.  Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.

Authors:  K Yoshikawa; K Honda; T Inamoto; H Shinohara; A Yamauchi; K Suga; T Okuyama; T Shimada; H Kodama; S Noguchi; A F Gazdar; Y Yamaoka; R Takahashi
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

6.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

Authors:  Q Zhong; C F Chen; S Li; Y Chen; C C Wang; J Xiao; P L Chen; Z D Sharp; W H Lee
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

Authors:  X Xu; Z Weaver; S P Linke; C Li; J Gotay; X W Wang; C C Harris; T Ried; C X Deng
Journal:  Mol Cell       Date:  1999-03       Impact factor: 17.970

8.  BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.

Authors:  J J Chen; D Silver; S Cantor; D M Livingston; R Scully
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

9.  A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1.

Authors:  M van der Looij; A M Cleton-Jansen; R van Eijk; H Morreau; M van Vliet; N Kuipers-Dijkshoorn; E Oláh; C J Cornelisse; P Devilee
Journal:  Genes Chromosomes Cancer       Date:  2000-03       Impact factor: 5.006

10.  Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

Authors:  U S Khoo; H Ozcelik; A N Cheung; L W Chow; H Y Ngan; S J Done; A C Liang; V W Chan; G K Au; W F Ng; C S Poon; Y F Leung; F Loong; P Ip; G S Chan; I L Andrulis; J Lu; F C Ho
Journal:  Oncogene       Date:  1999-08-12       Impact factor: 9.867

View more
  51 in total

1.  Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Authors:  Cindy E Jiménez-Ávila; Vanessa Villegas-Ruíz; Marta Zapata-Tarres; Alejandra E Rubio-Portillo; Eleazar I Pérez López; Juan C Zenteno; Sergio Juárez-Méndez
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

Review 2.  Aberrant RNA splicing and its functional consequences in cancer cells.

Authors:  James D Fackenthal; Lucy A Godley
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

3.  BRCA1 exon 11 a model of long exon splicing regulation.

Authors:  Michela Raponi; Lindsay D Smith; Marco Silipo; Cristiana Stuani; Emanuele Buratti; Diana Baralle
Journal:  RNA Biol       Date:  2014-03-18       Impact factor: 4.652

4.  Characterization of a novel germline BRCA1 splice variant, c.5332+4delA.

Authors:  Ciyu Yang; Sowmya Jairam; Kimberly A Amoroso; Mark E Robson; Michael F Walsh; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2017-11-28       Impact factor: 4.872

5.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 6.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

7.  AKT regulates BRCA1 stability in response to hormone signaling.

Authors:  Andrew C Nelson; Traci R Lyons; Christian D Young; Kirk C Hansen; Steven M Anderson; Jeffrey T Holt
Journal:  Mol Cell Endocrinol       Date:  2010-01-18       Impact factor: 4.102

Review 8.  Protein-protein interaction networks: how can a hub protein bind so many different partners?

Authors:  Chung-Jung Tsai; Buyong Ma; Ruth Nussinov
Journal:  Trends Biochem Sci       Date:  2009-12       Impact factor: 13.807

9.  Protein disorder in the human diseasome: unfoldomics of human genetic diseases.

Authors:  Uros Midic; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

10.  Alternative splicing and tumor progression.

Authors:  Claudia Ghigna; Cristina Valacca; Giuseppe Biamonti
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.